IDCBIS

What IDCBIS does

IDCBIS (Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud) is a public district-level health institute in Bogotá, Colombia, operating under the Secretaría Distrital de Salud. Formally created in 2017 from the predecessor Hemocentro Distrital (established 2001), it serves as the integrated platform for the city's blood, tissue, and advanced therapy services. Its core operations span the District Blood Bank (the only Colombian bank performing 100% NAT molecular testing), the District Tissue Bank (the only multipurpose tissue bank in Colombia and a Latin American reference for acellular dermis), the Public Cord Blood Bank (9,000+ units collected since 2013, 47 pediatric transplants facilitated), and the Advanced Therapies Unit operating Latin America's first large-scale GMP clean room (280m²). Supporting infrastructure includes the newly inaugurated Genomics Laboratory, a Molecular Immunohematology Laboratory (first in Colombia, second in Latin America), and a national reference Microbiology Laboratory, with proprietary products such as Dermaglic (acellular dermis for burn patients) and a granted patent on mesenchymal stem cell stimulation methods.

The institute operates as a non-commercial public entity serving the Bogotá public hospital network through the District Health Secretariat, with revenue flowing from public sources including the Sistema General de Regalías and the Fondo de Ciencia, Tecnología e Innovación. Its customer base is concentrated almost entirely within the Colombian public healthcare system — public hospitals, clinics, and the integrated health sub-networks (Centro Oriente, Sur Occidente, Norte) — though it operates targeted international collaborations (GCIAMT, IBGRL Bristol, IUCBC Argentina) for rare donor registries and translational research. The research arm, GIMTTyC, holds Minciencias A1 classification (the top tier among more than 7,000 Colombian research groups) and has produced over 60 indexed publications. Multiple international certifications (CAT Foundation, ISO 30401, INVIMA GMP) and consecutive Bogotá civic awards underscore its institutional standing as a Latin American reference center in transfusion medicine, tissue banking, and emerging advanced cellular therapies.

Name

IDCBIS

Legal name

Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud

Website

https://idcbis.org.co

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

251–500 employees

Short description

IDCBIS is a Bogotá public health institute operating the city's district blood bank, tissue bank, cord blood bank, advanced therapies unit, and genomics laboratory, serving the public hospital network and conducting biotechnology research.

Ownership category

akta.pro rank

Product category

Public Health Biotechnology & Transfusion Medicine

NAICS

Blood and Organ Banks (621991), Medical Laboratories (621511)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

akta.pro secondary industries

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)

Keywords

• Blood banking services
• Tissue banking services
• Cellular therapy research
• Public health biotechnology
• Advanced therapy manufacturing

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Blood and Tissue Component Supply: As a public district institute, IDCBIS supplies blood components and tissues to public hospitals and clinics in Bogotá through the District Health Secretariat network. Services are provided as part of the public healthcare system.
2. Research and Development Services: The institute conducts scientific research funded by government programs including Sistema General de Regalías (General Royalties System) and Fondo de Ciencia, Tecnología e Innovación. Research includes advanced therapies, biotechnology development, and public health initiatives.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

IDCBIS is a district government health institute in Bogotá that operates a District Blood Bank, District Tissue Bank, Public Cord Blood Bank, and Advanced Therapies Unit. It supplies blood components, tissues (skin, corneas, bone, amniotic membrane), umbilical cord blood units, and advanced cellular therapies to public hospitals and conducts biomedical research.

Product overview

IDCBIS is a public health institute in Bogotá, Colombia operating as a unified platform of specialized banks, research units, and advanced laboratories. The core offerings include three main tissue/cell banks: the District Blood Bank (Banco Distrital de Sangre), the District Tissue Bank (Banco Distrital de Tejidos), and the Public Cord Blood Bank (Banco Público de Sangre de Cordón Umbilical). These are supported by the Advanced Therapies Unit (Unidad de Terapias Avanzadas) for regenerative medicine research, the GIMTTyC research group (A1 classified by MinCiencias), and specialized programs including DarCélulas (National Donor Registry) and Donantes Únicos (Rare Phenotype Donors). Advanced facilities include the Sala Blanca GMP clean room for therapy manufacturing, a Genomics Laboratory for precision medicine, a Molecular Immunohematology Laboratory, and a Microbiology Laboratory. The institute also develops products like Dermaglic (acellular dermis for burns). All operations are conducted under international quality certifications (ISO 30401, CAT Foundation, INVIMA).

Differentiator

Problem solved

Functional benefit

Products and services

• Banco Distrital de Sangre (District Blood Bank)

Quantifiable outcome

• 673,817 blood donations collected over 20 years
• +5 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature7 records

Partnerships

13 partnerships are on record, tiered core and minor.

• Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC)coreStrategic or Co-development Partner · 4 September 2025Framework cooperation agreement signed between IDCBIS and IUCBC of Argentina to strengthen translational research with emphasis on advanced therapy development and innovation, consolidating a knowledge and technology ecosystem in biomedicine that transcends borders.
• Grupo Cooperativo Iberoamericano de Medicina Transfusional (GCIAMT)coreStrategic or Co-development PartnerCollaboration to consolidate the first Ibero-American registry of rare blood donors, which will be incorporated into the World Rare Donor Panel managed by the International Blood Group Reference Laboratory in Bristol, UK.
• International Blood Group Reference Laboratory (IBGRL) - Bristol, UKcoreTechnology or IntegrationUK reference laboratory managing the World Rare Donor Panel, established as an initiative of WHO and ISBT to facilitate identification of rare donors worldwide and rare blood management between countries.
• Centro de Biología Molecular Severo Ochoa (CBM) - CSIC, SpaincoreStrategic or Co-development PartnerCollaboration with the Molecular Modeling Group led by Dr. Paulino Gómez-Puertas on design of peptides against SARS-CoV-2 variants, combining computational modeling and molecular biology technologies.
• Secretaría Distrital de Salud de BogotácoreOthersMain government partner providing institutional oversight and funding through the District Health Secretariat. IDCBIS is linked to the Secretary of Health and operates within the public health system.
• Integrated Health Sub-networks (Subredes Integradas de Servicios en Salud)coreOthersHealth service sub-networks: Centro Oriente, Sur Occidente, and Norte, which are part of the board of directors and receive blood component and tissue distributions.
• Pontificia Universidad JaverianacoreStrategic or Co-development PartnerOne of 9 founding entities and member of the Board of Directors. Contributes to research, academic formation, and scientific collaboration.
• Universidad Nacional de ColombiacoreStrategic or Co-development PartnerFounding entity and Board member. Major public university contributing to research and talent formation in biotechnology and health sciences.
• Universidad de Los AndescoreStrategic or Co-development PartnerFounding entity and Board member. Private university contributing academic excellence and research capabilities.
• Instituto Nacional de CancerologíacoreStrategic or Co-development PartnerFounding entity and Board member. National cancer institute providing clinical expertise and research collaboration in oncology and hematology.
• Colegio Mayor de Nuestra Señora del RosariominorStrategic or Co-development PartnerLater addition to Board of Directors, contributing academic perspective.
• Secretaría de Salud de BogotácoreOthersGovernment entity providing financial and administrative support for genomics laboratory and various research projects through Sistema General de Regalías.
• Hospital Simón BolívarminorOthersBurns unit reference hospital where tissue bank professionals conducted training visits for Chilean professionals.

Scale indicators9 records

Recent moves11 records

Expansion highlights6 records

Broad incumbents

• Sanquin Blood Supply Foundation: Dutch national blood bank combining transfusion medicine, cellular therapy, and diagnostic services with research capabilities. Closely comparable to IDCBIS as a multi-modality public blood bank with tissue banking and advanced therapy operations, though operating at significantly larger national scale.
• Vitalant: One of the largest blood service providers in the United States operating blood collection, component manufacturing, transfusion medicine, and specialized cellular therapy services. Comparable in product mix (whole blood components, apheresis, specialty products) and reliance on regional hospital networks.
• NHS Blood and Transplant: UK public-sector body responsible for blood, tissues, stem cells, and organ donation including the British Bone Marrow Registry. Comparable in combining blood/tissue banking, cord blood, donor registries, and advanced therapy research under a single public-health mandate.
• Canadian Blood Services: Canada's national blood operator managing collection, manufacturing, stem cell registry (OneMatch), and organ/tissue programs. Comparable as a publicly-funded blood and biologic service provider with cord blood and donor registry operations alongside traditional transfusion services.

Direct peers

• New York Blood Center: Independent blood center operating collection, component processing, immunohematology reference lab, and a cord blood banking program (National Cord Blood Program). Directly comparable in scope — blood bank + cord blood bank + research institute structure.
• Barcelona Tissue Bank (BST-BTB): European tissue bank operating under the Banc de Sang i Teixits (BST) in Catalonia, providing musculoskeletal, cardiovascular, skin, and ocular tissue processing and distribution with active research programs. Comparable as a public-sector multipurpose tissue bank with both transplant distribution and R&D in advanced therapies — the CAT Foundation certification body for IDCBIS.

Regional players

• Fundação Hemominas: State-level public blood network in Minas Gerais, Brazil operating blood collection, processing, and distribution across a large territorial network. Comparable as a Latin American public-sector blood bank serving a public hospital system with similar regulatory and operational constraints.
• Banco de Sangre del Hospital de Pediatría Garrahan: Pediatric hospital-based blood bank in Argentina specializing in transfusion medicine for pediatric oncology and rare disease patients. Comparable as a Latin American public blood bank focused on pediatric and complex transfusion cases, including cord blood applications.

Emerging players

• Cryo-Cell International: US-based cord blood banking company offering family and public cord blood storage services. Comparable as a focused cord blood banking operator, though operating in a private/commercial model rather than IDCBIS's public-distribution model.
• LifeBank: Nigerian health-tech company building blood and medical supply distribution infrastructure across Africa. Comparable as an emerging-market blood logistics and supply operator, though focused on distribution technology rather than in-house tissue manufacturing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/IDCBIS

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDCBIS